APO Research
Talk to an analyst

APO RESEARCH · REPORT

Japanese Encephalitis Vaccines

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Japanese Encephalitis Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025186 pages

Choose your research edition.

Industry ResearchJapanese Encephalitis Vaccines Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Japanese Encephalitis Vaccines Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Japanese Encephalitis Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Japanese Encephalitis Vaccines Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Japanese Encephalitis Vaccines Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Japanese Encephalitis Vaccines market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Japanese Encephalitis Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Japanese Encephalitis Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Japanese Encephalitis Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Japanese Encephalitis Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Japanese Encephalitis Vaccines include Bharat Biotech, Sanofi Pasteur, Valneva Products, GlaxoSmithKline and China National Biotec Group, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Japanese Encephalitis Vaccines market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Japanese Encephalitis Vaccines and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Japanese Encephalitis Vaccines sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Japanese Encephalitis Vaccines market size, projected growth trends, production technologies, key applications, and end-use industries.

Japanese Encephalitis Vaccines Segment by Company

Bharat Biotech

Sanofi Pasteur

Valneva Products

GlaxoSmithKline

China National Biotec Group

Japanese Encephalitis Vaccines Segment by Type

Attenuated Vaccines

Inactivated Vaccines

Japanese Encephalitis Vaccines Segment by Application

Adults

Children

Japanese Encephalitis Vaccines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Japanese Encephalitis Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Japanese Encephalitis Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Japanese Encephalitis Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Japanese Encephalitis Vaccines market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Japanese Encephalitis Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Japanese Encephalitis Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Japanese Encephalitis Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Japanese Encephalitis Vaccines Industry Trends Table 2. Japanese Encephalitis Vaccines Industry Drivers Table 3. Japanese Encephalitis Vaccines Industry Opportunities and Challenges Table 4. Japanese Encephalitis Vaccines Industry Restraints Table 5. Global Japanese Encephalitis Vaccines Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Japanese Encephalitis Vaccines Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Japanese Encephalitis Vaccines Sales by Manufacturers (k doses) & (2021-2026) Table 8. Global Japanese Encephalitis Vaccines Sales Market Share by Manufacturers Table 9. Global Japanese Encephalitis Vaccines Average Sales Price (US$/dose) of Manufacturers (2021-2026) Table 10. Global Japanese Encephalitis Vaccines Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Japanese Encephalitis Vaccines Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Japanese Encephalitis Vaccines Manufacturers, Product Type & Application Table 13. Global Japanese Encephalitis Vaccines Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Japanese Encephalitis Vaccines by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Attenuated Vaccines Table 17. Major Manufacturers of Inactivated Vaccines Table 18. Global Japanese Encephalitis Vaccines Sales by Type 2021 VS 2025 VS 2032 (k doses) Table 19. Global Japanese Encephalitis Vaccines Sales by Type (2021-2026) & (k doses) Table 20. Global Japanese Encephalitis Vaccines Sales by Type (2027-2032) & (k doses) Table 21. Global Japanese Encephalitis Vaccines Sales Market Share by Type (2021-2026) Table 22. Global Japanese Encephalitis Vaccines Sales Market Share by Type (2027-2032) Table 23. Global Japanese Encephalitis Vaccines Revenue by Type 2021 VS 2025 VS 2032 (k doses) Table 24. Global Japanese Encephalitis Vaccines Revenue by Type (2021-2026) & (k doses) Table 25. Global Japanese Encephalitis Vaccines Revenue by Type (2027-2032) & (k doses) Table 26. Global Japanese Encephalitis Vaccines Revenue Market Share by Type (2021-2026) Table 27. Global Japanese Encephalitis Vaccines Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Adults Table 29. Major Manufacturers of Children Table 30. Global Japanese Encephalitis Vaccines Sales by Application 2021 VS 2025 VS 2032 (k doses) Table 31. Global Japanese Encephalitis Vaccines Sales by Application (2021-2026) & (k doses) Table 32. Global Japanese Encephalitis Vaccines Sales by Application (2027-2032) & (k doses) Table 33. Global Japanese Encephalitis Vaccines Sales Market Share by Application (2021-2026) Table 34. Global Japanese Encephalitis Vaccines Sales Market Share by Application (2027-2032) Table 35. Global Japanese Encephalitis Vaccines Revenue by Application 2021 VS 2025 VS 2032 (k doses) Table 36. Global Japanese Encephalitis Vaccines Revenue by Application (2021-2026) & (k doses) Table 37. Global Japanese Encephalitis Vaccines Revenue by Application (2027-2032) & (k doses) Table 38. Global Japanese Encephalitis Vaccines Revenue Market Share by Application (2021-2026) Table 39. Global Japanese Encephalitis Vaccines Revenue Market Share by Application (2027-2032) Table 40. Global Japanese Encephalitis Vaccines Sales by Region: 2021 VS 2025 VS 2032 (k doses) Table 41. Global Japanese Encephalitis Vaccines Sales by Region (2021-2026) & (k doses) Table 42. Global Japanese Encephalitis Vaccines Sales Market Share by Region (2021-2026) Table 43. Global Japanese Encephalitis Vaccines Sales Forecasted by Region (2027-2032) & (k doses) Table 44. Global Japanese Encephalitis Vaccines Sales Forecasted Market Share by Region (2027-2032) Table 45. North America Japanese Encephalitis Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k doses) Table 46. North America Japanese Encephalitis Vaccines Sales by Country (2021-2026) & (k doses) Table 47. North America Japanese Encephalitis Vaccines Sales by Country (2027-2032) & (k doses) Table 48. Europe Japanese Encephalitis Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k doses) Table 49. Europe Japanese Encephalitis Vaccines Sales by Country (2021-2026) & (k doses) Table 50. Europe Japanese Encephalitis Vaccines Sales by Country (2027-2032) & (k doses) Table 51. Asia Pacific Japanese Encephalitis Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k doses) Table 52. Asia Pacific Japanese Encephalitis Vaccines Sales by Country (2021-2026) & (k doses) Table 53. Asia Pacific Japanese Encephalitis Vaccines Sales by Country (2027-2032) & (k doses) Table 54. South America, Middle East and Africa Japanese Encephalitis Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k doses) Table 55. South America, Middle East and Africa Japanese Encephalitis Vaccines Sales by Country (2021-2026) & (k doses) Table 56. South America, Middle East and Africa Japanese Encephalitis Vaccines Sales by Country (2027-2032) & (k doses) Table 57. Global Japanese Encephalitis Vaccines Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Japanese Encephalitis Vaccines Revenue by Region (2021-2026) & (US$ Million) Table 59. Global Japanese Encephalitis Vaccines Revenue by Region (2027-2032) & (US$ Million) Table 60. Global Japanese Encephalitis Vaccines Revenue Market Share by Region (2021-2026) Table 61. Global Japanese Encephalitis Vaccines Revenue Market Share by Region (2027-2032) Table 62. Bharat Biotech Company Information Table 63. Bharat Biotech Business Overview Table 64. Bharat Biotech Japanese Encephalitis Vaccines Sales (k doses), Price (US$/dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Bharat Biotech Japanese Encephalitis Vaccines Product Portfolio Table 66. Bharat Biotech Recent Development Table 67. Sanofi Pasteur Company Information Table 68. Sanofi Pasteur Business Overview Table 69. Sanofi Pasteur Japanese Encephalitis Vaccines Sales (k doses), Price (US$/dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Sanofi Pasteur Japanese Encephalitis Vaccines Product Portfolio Table 71. Sanofi Pasteur Recent Development Table 72. Valneva Products Company Information Table 73. Valneva Products Business Overview Table 74. Valneva Products Japanese Encephalitis Vaccines Sales (k doses), Price (US$/dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Valneva Products Japanese Encephalitis Vaccines Product Portfolio Table 76. Valneva Products Recent Development Table 77. GlaxoSmithKline Company Information Table 78. GlaxoSmithKline Business Overview Table 79. GlaxoSmithKline Japanese Encephalitis Vaccines Sales (k doses), Price (US$/dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. GlaxoSmithKline Japanese Encephalitis Vaccines Product Portfolio Table 81. GlaxoSmithKline Recent Development Table 82. China National Biotec Group Company Information Table 83. China National Biotec Group Business Overview Table 84. China National Biotec Group Japanese Encephalitis Vaccines Sales (k doses), Price (US$/dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. China National Biotec Group Japanese Encephalitis Vaccines Product Portfolio Table 86. China National Biotec Group Recent Development Table 87. Key Raw Materials Table 88. Raw Materials Key Suppliers Table 89. Japanese Encephalitis Vaccines Distributors List Table 90. Japanese Encephalitis Vaccines Customers List Table 91. Research Programs/Design for This Report Table 92. Authors List of This Report Table 93. Secondary Sources Table 94. Primary Sources List of Figures Figure 1. Japanese Encephalitis Vaccines Product Image Figure 2. Global Japanese Encephalitis Vaccines Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Japanese Encephalitis Vaccines Market Size (2021-2032) & (US$ Million) Figure 4. Global Japanese Encephalitis Vaccines Sales (2021-2032) & (k doses) Figure 5. Global Japanese Encephalitis Vaccines Average Price (US$/dose) & (2021-2032) Figure 6. Global Top 5 and 10 Japanese Encephalitis Vaccines Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Attenuated Vaccines Image Figure 9. Inactivated Vaccines Image Figure 10. Global Japanese Encephalitis Vaccines Sales by Type (2021 VS 2025 VS 2032) & (k doses) Figure 11. Global Japanese Encephalitis Vaccines Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Japanese Encephalitis Vaccines Sales Market Share by Type (2021-2032) Figure 13. Global Japanese Encephalitis Vaccines Revenue by Type (2021 VS 2025 VS 2032) & (k doses) Figure 14. Global Japanese Encephalitis Vaccines Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Japanese Encephalitis Vaccines Revenue Market Share by Type (2021-2032) Figure 16. Adults Image Figure 17. Children Image Figure 18. Global Japanese Encephalitis Vaccines Sales by Application (2021 VS 2025 VS 2032) & (k doses) Figure 19. Global Japanese Encephalitis Vaccines Sales Market Share 2021 VS 2025 VS 2032 Figure 20. Global Japanese Encephalitis Vaccines Sales Market Share by Application (2021-2032) Figure 21. Global Japanese Encephalitis Vaccines Revenue by Application (2021 VS 2025 VS 2032) & (k doses) Figure 22. Global Japanese Encephalitis Vaccines Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Japanese Encephalitis Vaccines Revenue Market Share by Application (2021-2032) Figure 24. North America Japanese Encephalitis Vaccines Sales and Growth Rate (2021-2032) & (k doses) Figure 25. North America Japanese Encephalitis Vaccines Sales Market Share by Country (2021-2032) Figure 26. U.S. Japanese Encephalitis Vaccines Sales and Growth Rate (2021-2032) & (k doses) Figure 27. Canada Japanese Encephalitis Vaccines Sales and Growth Rate (2021-2032) & (k doses) Figure 28. Mexico Japanese Encephalitis Vaccines Sales and Growth Rate (2021-2032) & (k doses) Figure 29. Europe Japanese Encephalitis Vaccines Sales and Growth Rate (2021-2032) & (k doses) Figure 30. Europe Japanese Encephalitis Vaccines Sales Market Share by Country (2021-2032) Figure 31. Germany Japanese Encephalitis Vaccines Sales and Growth Rate (2021-2032) & (k doses) Figure 32. France Japanese Encephalitis Vaccines Sales and Growth Rate (2021-2032) & (k doses) Figure 33. U.K. Japanese Encephalitis Vaccines Sales and Growth Rate (2021-2032) & (k doses) Figure 34. Italy Japanese Encephalitis Vaccines Sales and Growth Rate (2021-2032) & (k doses) Figure 35. Netherlands Japanese Encephalitis Vaccines Sales and Growth Rate (2021-2032) & (k doses) Figure 36. Asia Pacific Japanese Encephalitis Vaccines Sales and Growth Rate (2021-2032) & (k doses) Figure 37. Asia Pacific Japanese Encephalitis Vaccines Sales Market Share by Country (2021-2032) Figure 38. China Japanese Encephalitis Vaccines Sales and Growth Rate (2021-2032) & (k doses) Figure 39. Japan Japanese Encephalitis Vaccines Sales and Growth Rate (2021-2032) & (k doses) Figure 40. South Korea Japanese Encephalitis Vaccines Sales and Growth Rate (2021-2032) & (k doses) Figure 41. Southeast Asia Japanese Encephalitis Vaccines Sales and Growth Rate (2021-2032) & (k doses) Figure 42. India Japanese Encephalitis Vaccines Sales and Growth Rate (2021-2032) & (k doses) Figure 43. Australia Japanese Encephalitis Vaccines Sales and Growth Rate (2021-2032) & (k doses) Figure 44. South America, Middle East and Africa Japanese Encephalitis Vaccines Sales and Growth Rate (2021-2032) & (k doses) Figure 45. South America, Middle East and Africa Japanese Encephalitis Vaccines Sales Market Share by Country (2021-2032) Figure 46. Brazil Japanese Encephalitis Vaccines Sales and Growth Rate (2021-2032) & (k doses) Figure 47. South Africa Japanese Encephalitis Vaccines Sales and Growth Rate (2021-2032) & (k doses) Figure 48. Saudi Arabia Japanese Encephalitis Vaccines Sales and Growth Rate (2021-2032) & (k doses) Figure 49. Turkey Japanese Encephalitis Vaccines Sales and Growth Rate (2021-2032) & (k doses) Figure 50. Argentina Japanese Encephalitis Vaccines Sales and Growth Rate (2021-2032) & (k doses) Figure 51. UAE Japanese Encephalitis Vaccines Sales and Growth Rate (2021-2032) & (k doses) Figure 52. Egypt Japanese Encephalitis Vaccines Sales and Growth Rate (2021-2032) & (k doses) Figure 53. Chile Japanese Encephalitis Vaccines Sales and Growth Rate (2021-2032) & (k doses) Figure 54. Global Japanese Encephalitis Vaccines Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Global Japanese Encephalitis Vaccines Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 56. North America Japanese Encephalitis Vaccines Revenue (2021-2032) & (US$ Million) Figure 57. North America Japanese Encephalitis Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 58. Europe Japanese Encephalitis Vaccines Revenue (2021-2032) & (US$ Million) Figure 59. Europe Japanese Encephalitis Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Asia-Pacific Japanese Encephalitis Vaccines Revenue (2021-2032) & (US$ Million) Figure 61. Asia-Pacific Japanese Encephalitis Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. South America, Middle East and Africa Japanese Encephalitis Vaccines Revenue (2021-2032) & (US$ Million) Figure 63. South America, Middle East and Africa Japanese Encephalitis Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Japanese Encephalitis Vaccines Value Chain Figure 65. Manufacturing Cost Structure Figure 66. Japanese Encephalitis Vaccines Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Attenuated Vaccines
  • Inactivated Vaccines
Applications
  • Adults
  • Children
Companies covered
  • Bharat Biotech
  • Sanofi Pasteur
  • Valneva Products
  • GlaxoSmithKline
  • China National Biotec Group

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Japanese Encephalitis Vaccines Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Japanese Encephalitis Vaccines Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Japanese Encephalitis Vaccines Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Japanese Encephalitis Vaccines Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Japanese Encephalitis Vaccines Market Dynamics
  1. 2.1 Japanese Encephalitis Vaccines Industry Trends
  2. 2.2 Japanese Encephalitis Vaccines Industry Drivers
  3. 2.3 Japanese Encephalitis Vaccines Industry Opportunities and Challenges
  4. 2.4 Japanese Encephalitis Vaccines Industry Restraints
3 Japanese Encephalitis Vaccines Market by Manufacturers
  1. 3.1 Global Japanese Encephalitis Vaccines Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Japanese Encephalitis Vaccines Sales by Manufacturers (2021-2026)
  3. 3.3 Global Japanese Encephalitis Vaccines Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Japanese Encephalitis Vaccines Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Japanese Encephalitis Vaccines Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Japanese Encephalitis Vaccines Manufacturers, Product Type & Application
  7. 3.7 Global Japanese Encephalitis Vaccines Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Japanese Encephalitis Vaccines Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Japanese Encephalitis Vaccines Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Japanese Encephalitis Vaccines Tier 1, Tier 2, and Tier 3
4 Japanese Encephalitis Vaccines Market by Type
  1. 4.1 Japanese Encephalitis Vaccines Type Introduction
  2. 4.1.1 Attenuated Vaccines
  3. 4.1.2 Inactivated Vaccines
  4. 4.2 Global Japanese Encephalitis Vaccines Sales by Type
  5. 4.2.1 Global Japanese Encephalitis Vaccines Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Japanese Encephalitis Vaccines Sales by Type (2021-2032)
  7. 4.2.3 Global Japanese Encephalitis Vaccines Sales Market Share by Type (2021-2032)
  8. 4.3 Global Japanese Encephalitis Vaccines Revenue by Type
  9. 4.3.1 Global Japanese Encephalitis Vaccines Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Japanese Encephalitis Vaccines Revenue by Type (2021-2032)
  11. 4.3.3 Global Japanese Encephalitis Vaccines Revenue Market Share by Type (2021-2032)
5 Japanese Encephalitis Vaccines Market by Application
  1. 5.1 Japanese Encephalitis Vaccines Application Introduction
  2. 5.1.1 Adults
  3. 5.1.2 Children
  4. 5.2 Global Japanese Encephalitis Vaccines Sales by Application
  5. 5.2.1 Global Japanese Encephalitis Vaccines Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Japanese Encephalitis Vaccines Sales by Application (2021-2032)
  7. 5.2.3 Global Japanese Encephalitis Vaccines Sales Market Share by Application (2021-2032)
  8. 5.3 Global Japanese Encephalitis Vaccines Revenue by Application
  9. 5.3.1 Global Japanese Encephalitis Vaccines Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Japanese Encephalitis Vaccines Revenue by Application (2021-2032)
  11. 5.3.3 Global Japanese Encephalitis Vaccines Revenue Market Share by Application (2021-2032)
6 Global Japanese Encephalitis Vaccines Sales by Region
  1. 6.1 Global Japanese Encephalitis Vaccines Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Japanese Encephalitis Vaccines Sales by Region (2021-2032)
  3. 6.2.1 Global Japanese Encephalitis Vaccines Sales by Region (2021-2026)
  4. 6.2.2 Global Japanese Encephalitis Vaccines Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Japanese Encephalitis Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Japanese Encephalitis Vaccines Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Japanese Encephalitis Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Japanese Encephalitis Vaccines Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Japanese Encephalitis Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Japanese Encephalitis Vaccines Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Japanese Encephalitis Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Japanese Encephalitis Vaccines Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Japanese Encephalitis Vaccines Revenue by Region
  1. 7.1 Global Japanese Encephalitis Vaccines Revenue by Region
  2. 7.1.1 Global Japanese Encephalitis Vaccines Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Japanese Encephalitis Vaccines Revenue by Region (2021-2026)
  4. 7.1.3 Global Japanese Encephalitis Vaccines Revenue by Region (2027-2032)
  5. 7.1.4 Global Japanese Encephalitis Vaccines Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Japanese Encephalitis Vaccines Revenue (2021-2032)
  8. 7.2.2 North America Japanese Encephalitis Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Japanese Encephalitis Vaccines Revenue (2021-2032)
  11. 7.3.2 Europe Japanese Encephalitis Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Japanese Encephalitis Vaccines Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Japanese Encephalitis Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Japanese Encephalitis Vaccines Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Japanese Encephalitis Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Bharat Biotech
  2. 8.1.1 Bharat Biotech Company Information
  3. 8.1.2 Bharat Biotech Business Overview
  4. 8.1.3 Bharat Biotech Japanese Encephalitis Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Bharat Biotech Japanese Encephalitis Vaccines Product Portfolio
  6. 8.1.5 Bharat Biotech Recent Developments
  7. 8.2 Sanofi Pasteur
  8. 8.2.1 Sanofi Pasteur Company Information
  9. 8.2.2 Sanofi Pasteur Business Overview
  10. 8.2.3 Sanofi Pasteur Japanese Encephalitis Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Sanofi Pasteur Japanese Encephalitis Vaccines Product Portfolio
  12. 8.2.5 Sanofi Pasteur Recent Developments
  13. 8.3 Valneva Products
  14. 8.3.1 Valneva Products Company Information
  15. 8.3.2 Valneva Products Business Overview
  16. 8.3.3 Valneva Products Japanese Encephalitis Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Valneva Products Japanese Encephalitis Vaccines Product Portfolio
  18. 8.3.5 Valneva Products Recent Developments
  19. 8.4 GlaxoSmithKline
  20. 8.4.1 GlaxoSmithKline Company Information
  21. 8.4.2 GlaxoSmithKline Business Overview
  22. 8.4.3 GlaxoSmithKline Japanese Encephalitis Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 GlaxoSmithKline Japanese Encephalitis Vaccines Product Portfolio
  24. 8.4.5 GlaxoSmithKline Recent Developments
  25. 8.5 China National Biotec Group
  26. 8.5.1 China National Biotec Group Company Information
  27. 8.5.2 China National Biotec Group Business Overview
  28. 8.5.3 China National Biotec Group Japanese Encephalitis Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 China National Biotec Group Japanese Encephalitis Vaccines Product Portfolio
  30. 8.5.5 China National Biotec Group Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Japanese Encephalitis Vaccines Value Chain Analysis
  2. 9.1.1 Japanese Encephalitis Vaccines Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Japanese Encephalitis Vaccines Production Mode & Process
  6. 9.2 Japanese Encephalitis Vaccines Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Japanese Encephalitis Vaccines Distributors
  9. 9.2.3 Japanese Encephalitis Vaccines Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst